Cognitive Stimulation Therapy (CST) enhances the effects of Alzheimer’s disease medicine

Cognitive Stimulation Therapy (CST) enhances the effects of Alzheimer’s disease medicine A key finding from the recently released 2nd systematic Cochrane review (Woods et al., 2023) is the confirmation that medication combined with CST results […]

DETAIL

EU GRANT

Respected dementia experts and Brain+ get EU grant to research how to optimize digital at-home treatments for people with dementia The EU Joint Programme – Neurodegenerative Disease Research has granted 496,000SEK (or 48,405 euros) to […]

Caroline Grube-Nagel   Brain+ Blog
DETAIL

MATSUMAE BUSINESS CUP

Brain+ showcases its digital dementia products At the Danish-Japanese Welfare and Health Tech Business Conference Brain+ is part of a group of Danish welfare and health tech companies that have been invited to present their […]

DETAIL

CONCLUSION EU PROJECT & VALIDATION OF TWO TECHNOLOGIES

Successful conclusion of EU project Alzheimer’s Detect & Prevent  with early validation of two Brain+ DTx technologies and extra funding  The information communicated in this announcement is “inside information” for the purposes of article 7 of […]

DETAIL

Brain+ completes Swedish research version of its dementia product

Brain+ completes Swedish research version of its dementia product with the Research Institutes of Sweden and extends the collaboration A strong Swedish partner research network Brain+ has over the last three years entered multiple Alzheimer’s […]

Caroline Grube-Nagel   Brain+ Blog
DETAIL

Implementation of an ISO 13485 for Medical Devices

Brain+ completes the implementation of an ISO 13485 Quality Management System for Medical Devices Brain+ has successfully completed the implementation of an ISO 13485-compliant Quality Management System (QMS). Such a system helps to set standards […]

Caroline Grube-Nagel   Brain+ Blog
DETAIL

Leading dementia researcher joins Brain+

Brain+ adds new clinical and development competences To accelerate and support market access of its digital dementia product portfolio Rising star clinical dementia researcher to join the company in a new position as Clinical Director […]

DETAIL

CST Therapist Companion advancing

Brain+ further advances its first digital dementia product, Cognitive Stimulation Therapy (CST) – Therapist Companion Commercial launch in Denmark will be November 1, 2022 Adaptation of a UK product version for the United Kingdom starts […]

DETAIL

Brain+ begins early activity and brand building in the US

Brain+ begins early activity and brand building in the US The United States (US) is a key future market for Brain+, and early brand building and exploration is now ongoing Brain+ has been selected and […]

DETAIL

First milestone met

Brain+ meets milestone with Rox Health (Roche Germany) Rox Health has approved the German version of Brain+’s first digital dementia product, CST-Therapist Companion, for commercial launch.  Meeting this milestone unlocks access for Brain+ to additional […]

DETAIL